Other Species / Isoforms
  RPL28 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S2-p
______MsAHLQWMV
0 2
RPL28 (human) ______MsAHLQWMV S2-p
RPL28 iso2 (human) ______MSAHLQWMV S2
RPL28 iso3 (human) ______MSAHLQWMV S2
RPL28 (mouse) ______MsAHLQWMV S2-p
RPL28 (rat) ______MSAHLQWMV S2
R11-m1
HLQWMVVrNCssFLI
0 1
RPL28 (human) HLQWMVVrNCssFLI R11-m1
RPL28 iso2 (human) HLQWMVVRNCSSFLI R11
RPL28 iso3 (human) HLQWMVVRNCSSFLI R11
RPL28 (mouse) HLQWMVVRNCSsFLI R11
RPL28 (rat) HLQWMVVRNCSSFLI R11
S14-p
WMVVrNCssFLIkRN
0 1
RPL28 (human) WMVVrNCssFLIkRN S14-p
RPL28 iso2 (human) WMVVRNCSSFLIKRN S14
RPL28 iso3 (human) WMVVRNCSSFLIKRN S14
RPL28 (mouse) WMVVRNCSsFLIKRN S14
RPL28 (rat) WMVVRNCSSFLIKRN S14
S15-p
MVVrNCssFLIkRNk
0 2
RPL28 (human) MVVrNCssFLIkRNk S15-p
RPL28 iso2 (human) MVVRNCSSFLIKRNK S15
RPL28 iso3 (human) MVVRNCSSFLIKRNK S15
RPL28 (mouse) MVVRNCSsFLIKRNK S15-p
RPL28 (rat) MVVRNCSSFLIKRNK S15
K19-ub
NCssFLIkRNkQTYs
0 5
RPL28 (human) NCssFLIkRNkQTYs K19-ub
RPL28 iso2 (human) NCSSFLIKRNKQTYS K19
RPL28 iso3 (human) NCSSFLIKRNKQTYS K19
RPL28 (mouse) NCSsFLIKRNKQTYS K19
RPL28 (rat) NCSSFLIKRNKQTYS K19
K22-ub
sFLIkRNkQTYsTEP
0 9
RPL28 (human) sFLIkRNkQTYsTEP K22-ub
RPL28 iso2 (human) SFLIKRNKQTYSTEP K22
RPL28 iso3 (human) SFLIKRNKQTYSTEP K22
RPL28 (mouse) sFLIKRNKQTYSTEP K22
RPL28 (rat) SFLIKRNKQTYSTEP K22
S26-p
kRNkQTYsTEPNNLk
0 1
RPL28 (human) kRNkQTYsTEPNNLk S26-p
RPL28 iso2 (human) KRNKQTYSTEPNNLK S26
RPL28 iso3 (human) KRNKQTYSTEPNNLK S26
RPL28 (mouse) KRNKQTYSTEPNNLk S26
RPL28 (rat) KRNKQTYSTEPNNLK S26
K33-ub
sTEPNNLkARNsFRY
Upstream
0 33
Treatment
  • MG132
RPL28 (human) sTEPNNLkARNsFRY K33-ub
RPL28 iso2 (human) STEPNNLKARNSFRY K33
RPL28 iso3 (human) STEPNNLKARNSFRY K33
RPL28 (mouse) STEPNNLkARNsFRY K33-ub
RPL28 (rat) STEPNNLKARNSFRY K33
K33-sm
sTEPNNLkARNsFRY
0 1
RPL28 (human) sTEPNNLkARNsFRY K33-sm
RPL28 iso2 (human) STEPNNLKARNSFRY K33
RPL28 iso3 (human) STEPNNLKARNSFRY K33
RPL28 (mouse) STEPNNLKARNsFRY K33
RPL28 (rat) STEPNNLKARNSFRY K33
K33-m1
sTEPNNLkARNsFRY
0 1
RPL28 (human) sTEPNNLkARNsFRY K33-m1
RPL28 iso2 (human) STEPNNLKARNSFRY K33
RPL28 iso3 (human) STEPNNLKARNSFRY K33
RPL28 (mouse) STEPNNLKARNsFRY K33
RPL28 (rat) STEPNNLKARNSFRY K33
S37-p
NNLkARNsFRYNGLI
0 13
RPL28 (human) NNLkARNsFRYNGLI S37-p
RPL28 iso2 (human) NNLKARNSFRYNGLI S37
RPL28 iso3 (human) NNLKARNSFRYNGLI S37
RPL28 (mouse) NNLkARNsFRYNGLI S37-p
RPL28 (rat) NNLKARNSFRYNGLI S37
K47-ub
YNGLIHRkTVGVEPA
0 22
RPL28 (human) YNGLIHRkTVGVEPA K47-ub
RPL28 iso2 (human) YNGLIHRKTVGVEPA K47
RPL28 iso3 (human) YNGLIHRKTVGVEPA K47
RPL28 (mouse) YNGLIHRkTVGVEPA K47-ub
RPL28 (rat) YNGLIHRKTVGVEAW K47
D56
VGVEPAADGkGVVVV
0 1
RPL28 (human) VGVEPAADGkGVVVV D56
RPL28 iso2 (human) VGVEPAADGKGVVVV D56
RPL28 iso3 (human) VGVEPAADGKGVVVV D56
RPL28 (mouse) VGVEPAAdGkGVVVV D56-ca
RPL28 (rat) VGVEAWPDGKGVVVV D56
K58-ub
VEPAADGkGVVVVIk
0 5
RPL28 (human) VEPAADGkGVVVVIk K58-ub
RPL28 iso2 (human) VEPAADGKGVVVVIK K58
RPL28 iso3 (human) VEPAADGKGVVVVIK K58
RPL28 (mouse) VEPAAdGkGVVVVMK K58-ub
RPL28 (rat) VEAWPDGKGVVVVMK K58
K58-ac
VEPAADGkGVVVVIk
0 1
RPL28 (human) VEPAADGkGVVVVIk K58-ac
RPL28 iso2 (human) VEPAADGKGVVVVIK K58
RPL28 iso3 (human) VEPAADGKGVVVVIK K58
RPL28 (mouse) VEPAAdGKGVVVVMK K58
RPL28 (rat) VEAWPDGKGVVVVMK K58
K58-sm
VEPAADGkGVVVVIk
0 1
RPL28 (human) VEPAADGkGVVVVIk K58-sm
RPL28 iso2 (human) VEPAADGKGVVVVIK K58
RPL28 iso3 (human) VEPAADGKGVVVVIK K58
RPL28 (mouse) VEPAAdGKGVVVVMK K58
RPL28 (rat) VEAWPDGKGVVVVMK K58
K65-ub
kGVVVVIkRRsGQRk
0 2
RPL28 (human) kGVVVVIkRRsGQRk K65-ub
RPL28 iso2 (human) KGVVVVIKRRSGQRK K65
RPL28 iso3 (human) KGVVVVIKRRSGQRK K65
RPL28 (mouse) kGVVVVMKRRSGQRk K65
RPL28 (rat) KGVVVVMKRRSGQRK K65
S68-p
VVVIkRRsGQRkPAT
0 2
RPL28 (human) VVVIkRRsGQRkPAT S68-p
RPL28 iso2 (human) VVVIKRRSGQRKPAT S68
RPL28 iso3 (human) VVVIKRRSGQRKPAT S68
RPL28 (mouse) VVVMKRRSGQRkPAT S68
RPL28 (rat) VVVMKRRSGQRKPAT S68
K19-ac
NCssFLIkRNkQTYs
0 1
RPL28 (human) NCssFLIkRNkQTYs K19-ac
RPL28 iso2 (human) NCSSFLIKRNKQTYS K19
RPL28 iso3 (human) NCSSFLIKRNKQTYS K19
RPL28 (mouse) NCSsFLIKRNKQTYS K19
RPL28 (rat) NCSSFLIKRNKQTYS K19
K72-ub
kRRsGQRkPATSyVR
0 12
RPL28 (human) kRRsGQRkPATSyVR K72-ub
RPL28 iso2 (human) KRRSGQRKPATSYVR K72
RPL28 iso3 (human) KRRSGQRKPATSYVR K72
RPL28 (mouse) KRRSGQRkPATSYVR K72-ub
RPL28 (rat) KRRSGQRKPATSYVR K72
Y77-p
QRkPATSyVRtTINk
0 1
RPL28 (human) QRkPATSyVRtTINk Y77-p
RPL28 iso2 (human) QRKPATSYVRTTINK Y77
RPL28 iso3 (human) QRKPATSYVRTTINK Y77
RPL28 (mouse) QRkPATSYVRTTINk Y77
RPL28 (rat) QRKPATSYVRTTINK Y77
T80-p
PATSyVRtTINkNAR
0 1
RPL28 (human) PATSyVRtTINkNAR T80-p
RPL28 iso2 (human) PATSYVRTTINKNAR T80
RPL28 iso3 (human) PATSYVRTTINKNAR T80
RPL28 (mouse) PATSYVRTTINkNAR T80
RPL28 (rat) PATSYVRTTINKNAR T80
K84-ub
yVRtTINkNARAtLs
0 30
RPL28 (human) yVRtTINkNARAtLs K84-ub
RPL28 iso2 (human) YVRTTINKNARATLS K84
RPL28 iso3 (human) YVRTTINKNARATLS K84
RPL28 (mouse) YVRTTINkNARATLs K84-ub
RPL28 (rat) YVRTTINKNARATLS K84
T89-p
INkNARAtLssIRHM
0 1
RPL28 (human) INkNARAtLssIRHM T89-p
RPL28 iso2 (human) INKNARATLSSIRHM T89
RPL28 iso3 (human) INKNARATLSSIRHM T89
RPL28 (mouse) INkNARATLssIRHM T89
RPL28 (rat) INKNARATLSSIRHM T89
S91-p
kNARAtLssIRHMIR
0 18
RPL28 (human) kNARAtLssIRHMIR S91-p
RPL28 iso2 (human) KNARATLSSIRHMIR S91
RPL28 iso3 (human) KNARATLSSIRHMIR S91
RPL28 (mouse) kNARATLssIRHMIR S91-p
RPL28 (rat) KNARATLSSIRHMIR S91
S92-p
NARAtLssIRHMIRK
0 17
RPL28 (human) NARAtLssIRHMIRK S92-p
RPL28 iso2 (human) NARATLSSIRHMIRK S92
RPL28 iso3 (human) NARATLSSIRHMIRK S92
RPL28 (mouse) NARATLssIRHMIRK S92-p
RPL28 (rat) NARATLSSIRHMIRK S92
K101-ac
RHMIRKNkyRPDLrM
0 3
RPL28 (human) RHMIRKNkyRPDLrM K101-ac
RPL28 iso2 (human) RHMIRKNKYRPDLRM K101
RPL28 iso3 (human) RHMIRKNKYRPDLRM K101
RPL28 (mouse) RHMIRKNKYRPDLRM K101
RPL28 (rat) RHMIRKNkYRPDLRM K101-ac
K101-ub
RHMIRKNkyRPDLrM
Upstream
0 3
Treatment
  • adriamycin
  • MG132
RPL28 (human) RHMIRKNkyRPDLrM K101-ub
RPL28 iso2 (human) RHMIRKNKYRPDLRM K101
RPL28 iso3 (human) RHMIRKNKYRPDLRM K101
RPL28 (mouse) RHMIRKNKYRPDLRM K101
RPL28 (rat) RHMIRKNKYRPDLRM K101
K101-sm
RHMIRKNkyRPDLrM
0 1
RPL28 (human) RHMIRKNkyRPDLrM K101-sm
RPL28 iso2 (human) RHMIRKNKYRPDLRM K101
RPL28 iso3 (human) RHMIRKNKYRPDLRM K101
RPL28 (mouse) RHMIRKNKYRPDLRM K101
RPL28 (rat) RHMIRKNKYRPDLRM K101
Y102-p
HMIRKNkyRPDLrMA
0 1
RPL28 (human) HMIRKNkyRPDLrMA Y102-p
RPL28 iso2 (human) HMIRKNKYRPDLRMV Y102
RPL28 iso3 (human) HMIRKNKYRPDLRMD Y102
RPL28 (mouse) HMIRKNKYRPDLRMA Y102
RPL28 (rat) HMIRKNkYRPDLRMA Y102
R107-m1
NkyRPDLrMAAIRRA
0 1
RPL28 (human) NkyRPDLrMAAIRRA R107-m1
RPL28 iso2 (human) NKYRPDLRMVSWGLG R107
RPL28 iso3 (human) NKYRPDLRMDMLAST R107
RPL28 (mouse) NKYRPDLRMAAIRRA R107
RPL28 (rat) NkYRPDLRMAAIRRA R107
S115-p
MAAIRRAsAILRSQk
Upstream
0 21
Treatment
  • metastatic potential
  • nocodazole
RPL28 (human) MAAIRRAsAILRSQk S115-p
RPL28 iso2 (human) gap -
RPL28 iso3 (human) gap -
RPL28 (mouse) MAAIRRAsAILRSQK S115-p
RPL28 (rat) MAAIRRASAILRSQK S115
K122-ub
sAILRSQkPVMVKRK
0 2
RPL28 (human) sAILRSQkPVMVKRK K122-ub
RPL28 iso2 (human) gap -
RPL28 iso3 (human) gap -
RPL28 (mouse) sAILRSQKPVVVKRK K122
RPL28 (rat) SAILRSQKPVVVkRK K122
K122-sm
sAILRSQkPVMVKRK
0 1
RPL28 (human) sAILRSQkPVMVKRK K122-sm
RPL28 iso2 (human) gap -
RPL28 iso3 (human) gap -
RPL28 (mouse) sAILRSQKPVVVKRK K122
RPL28 (rat) SAILRSQKPVVVkRK K122
K127
SQkPVMVKRKRTRPT
0 1
RPL28 (human) SQkPVMVKRKRTRPT K127
RPL28 iso2 (human) gap -
RPL28 iso3 (human) gap -
RPL28 (mouse) SQKPVVVKRKRtRPT K127
RPL28 (rat) SQKPVVVkRKRTRPT K127-ac
T131
VMVKRKRTRPTkSS_
0 1
RPL28 (human) VMVKRKRTRPTkSS_ T131
RPL28 iso2 (human) gap -
RPL28 iso3 (human) gap -
RPL28 (mouse) VVVKRKRtRPTKSS_ T131-p
RPL28 (rat) VVVkRKRTRPTKSS_ T131
K135-pro
RKRTRPTkSS_____
0 1
RPL28 (human) RKRTRPTkSS_____ K135-pro
RPL28 iso2 (human) gap -
RPL28 iso3 (human) gap -
RPL28 (mouse) RKRtRPTKSS_____ K135
RPL28 (rat) RKRTRPTKSS_____ K135